Champions Oncology CSBR
NASDAQ CSBR
$4.79 -0.14 (-2.72%)
As of: Sep 29, 2026 · 3:02 PM EDT

Champions Oncology (CSBR) Research & Development (2010 - 2026)

Updated

Champions Oncology's Research & Development was $2.34 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 12.6% from $2.08 million a year earlier and up 10.8% from the prior quarter.

Analysis

Champions Oncology (CSBR) Research & Development (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Champions Oncology's Research & Development was $9.35 million through Jul 31, 2026, up 25.4% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $9.08 million, up 33.1% from FY2025.

  • Research & Development shows a five-year compound annual growth rate of 4.8% (FY2021 to FY2026).
  • In earlier fiscal years, Research & Development was $6.83 million in FY2025 (-28.5%), $9.54 million in FY2024 (-17.3%), $11.55 million in FY2023 (+23.2%) and $9.37 million in FY2022 (+30.3%).
  • Quarterly Research & Development has moved between $1.45 million (fiscal Q1 2025) and $3.2 million (fiscal Q3 2023) over five years.
  • Compared with a year earlier, Research & Development has increased for five straight quarters, with growth averaging 11.5% over the last eight quarters.
  • The best year-over-year quarter for Research & Development over five years was fiscal Q2 2026 (growth of 54.9%); the worst was fiscal Q1 2025 (a decline of 47.9%).
  • Per Business Quant data, CSBR's Research & Development in the three fiscal quarters before Q1 2027 was $2.12 million (Q4 2026), $2.27 million (Q3 2026) and $2.62 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Iqvia Holdings 44.55 Bn 36.39 Bn 1.44 Bn -
2 Medpace Holdings 17.19 Bn 15.25 Bn 201.64 Mn -
3 Charles River Laboratories International 14.06 Bn 13.30 Bn 363.37 Mn -
4 Icon 13.44 Bn 10.55 Bn 479.29 Mn -
5 Fortrea Holdings 1.91 Bn 1.29 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 665.78 Mn -96.30 Mn 18.44 Mn 46.21 Mn
7 Evotec SE 565.34 Mn -1.01 Bn - -
8 Champions Oncology 68.06 Mn 43.71 Mn 7.70 Mn 2.34 Mn
9 MindWalk Holdings 62.59 Mn 26.81 Mn 1.61 Mn 921,603.43
10 Natural Alternatives International 10.67 Mn -22.35 Mn 383,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 2.34 Mn
Apr 30, 2026 2.12 Mn
Jan 31, 2026 2.27 Mn
Oct 31, 2025 2.62 Mn
Jul 31, 2025 2.08 Mn
Apr 30, 2025 1.96 Mn
Jan 31, 2025 1.72 Mn
Oct 31, 2024 1.69 Mn
Jul 31, 2024 1.45 Mn
Apr 30, 2024 2.05 Mn
Jan 31, 2024 2.19 Mn
Oct 31, 2023 2.52 Mn
Jul 31, 2023 2.79 Mn
Apr 30, 2023 2.85 Mn
Jan 31, 2023 3.20 Mn
Oct 31, 2022 2.60 Mn
Jul 31, 2022 2.89 Mn
Apr 30, 2022 2.59 Mn
Jan 31, 2022 2.18 Mn
Oct 31, 2021 2.30 Mn
API Access

Champions Oncology Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CSBR&period=max&api_key=YOUR_API_KEY